Eligibility, any sex, with Sepsis or Necrotising Enterocolitis Neonatal. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants With Sepsis or Necrotizing EnterocolitisPrimary· From 3 days of age until NICU discharge, which can occur at up to 1 year of age, and on average at 3 months old
Late-onset sepsis is defined as a positive blood culture treated with at least 5 days of antibiotics. Necrotizing enterocolitis was defined using Bell's staging criteria to include stage 2 or higher. The outcome was a binary indicator of whether either of these diagnoses was made or neither.
Group
Value
95% CI
Study Cohort
20
Study Cohort
124
Sponsor's own description
Behind the scenes pilot trial in the computer lab involving chart review to use neonatal intensive care unit data to create computer models predicting sepsis and necrotizing enterocolitis in very small premature infants
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other trials of No Intervention: Observational Cohort
Trials testing the same drug.
NCT07284771 — MUSCLE-ML: Multimodal Integration of Muscle Strength, Structure by Machine Learning for Precision Rehabilitation After A
· not yet recruiting
NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients
· not yet recruiting
NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery
· recruiting
NCT07475468 — CP382 - Intermittent Catheter (IC) PRO Panel Plan
· not yet recruiting
NCT07382570 — Natural Course of Congenital Hydronephrosis in Infants Aged 0-6 Months
· not yet recruiting
Other recruiting trials for Sepsis
Currently open trials in the same condition.
NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness
· recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis
· recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study
· recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK)
· recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit
· NA
· recruiting
Other University of Virginia trials
Trials by the same sponsor.
NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
· EARLY_PHASE1
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Virginia
Last refreshed: 17 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07254559.